Masumeh Rajabi Bazl

12PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 29, 2025
Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains.

Shima Aghaei, Mohammad Hossein Yadegari, Masoumeh Rajabibazl

|Mar 23, 2024
STAT protein family and cardiovascular diseases: overview of pathological mechanisms and therapeutic implications.

Ghader Babaei, Samin Sadraei, Maral Yarahmadi

|Feb 29, 2024
Inhibition of MiR-155 Using Exosomal Delivery of Antagomir Can Up-Regulate PTEN in Triple Negative Breast Cancer.

Javad Razaviyan, Majid Sirati-Sabet, Ali Tafti

|Nov 10, 2022
Global and Regional DNA methylation silencing of PPARγ Associated with Glioblastoma Multiforme Pathogenesis.

Esmaeel Babaeenezhad, Mostafa Moradi Sarabi, Masoumeh Rajabibazl

|Jul 07, 2022
Downregulation of NRARP exerts anti-tumor activities in the breast tumor cells depending on Wnt/β-catenin-mediated signals: The role of miR-130a-3p.

Jafar Poodineh, Majid Sirati-Sabet, Masoumeh Rajabibazl

Pageof 2